Marshall Wace North America’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,498
Closed -$225K 1394
2021
Q2
$225K Sell
5,498
-26,698
-83% -$1.04M ﹤0.01% 1329
2021
Q1
$1.3M Sell
32,196
-207,987
-87% -$11.3M 0.01% 952
2020
Q4
$14.2M Buy
240,183
+77,139
+47% +$3.98M 0.06% 312
2020
Q3
$7.93M Buy
+163,044
New +$6.85M 0.05% 317
2020
Q2
Sell
-97,230
Closed -$2.7M 1127
2020
Q1
$2.7M Buy
97,230
+95,711
+6,301% +$2.67M 0.02% 428
2019
Q4
$46K Sell
1,519
-61,311
-98% -$1.76M ﹤0.01% 1159
2019
Q3
$1.94M Sell
62,830
-136,670
-69% -$5.58M 0.01% 551
2019
Q2
$9.64M Buy
+199,500
New +$8.84M 0.06% 246

Other funds holding ADPT